Tuberous Sclerosis Complex Research
Tuberous Sclerosis Complex Research is a research topic within Physiology. Science Explorer counts 12k research works in it since 1950. 10.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on Tuberous Sclerosis Complex (TSC) and related disorders, including Lymphangioleiomyomatosis and Angiomyolipoma. It covers various aspects such as genetic mutations, neurological manifestations, use of mTOR inhibitors, diagnostic criteria, and the role of hamartin and tuberin proteins. Additionally, it explores the association with epilepsy and cognitive impairment.
- Tuberous Sclerosis Complex
- Lymphangioleiomyomatosis
- Angiomyolipoma
- mTOR Inhibitors
- Neurological Manifestations
- Genetic Mutations
- Epilepsy
- Diagnostic Criteria
- Hamartin and Tuberin Proteins
- Cognitive Impairment
- Research works
- 12k fractional, since 1950
- In the world top 10%
- 1.3k per year above
- Top-10% rate
- 10.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Tuberous Sclerosis Complex Research research?
By volume, the United States and China publish the most (531 and 370 works in 2022–2025).
By volume, 2022–2025
- 1 United States 531 works
- 2 China 370 works
- 3 India 152 works
- 4 Japan 123 works
- 5 Italy 83 works
- 6 Germany 70 works
- 7 United Kingdom 63 works
- 8 France 54 works
- 9 Türkiye 52 works
- 10 Canada 49 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Tuberous Sclerosis Complex Research research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Tuberous Sclerosis Complex Research research, followed by Harvard University and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 14 works
- 2 Harvard UniversityUnited States 12 works
- 3 All India Institute of Medical SciencesIndia 11 works
- 4 University of CincinnatiUnited States 10 works
- 5 Post Graduate Institute of Medical Education and ResearchIndia 9 works
- 6 Peking Union Medical College HospitalChina 9 works
- 7 Brigham and Women's HospitalUnited States 8 works
- 8 Sichuan UniversityChina 8 works
- 9 Cincinnati Children's Hospital Medical CenterUnited States 8 works
- 10 The University of OsakaJapan 7 works
Who are the leading researchers in Tuberous Sclerosis Complex Research?
The most-cited researchers publishing on Tuberous Sclerosis Complex Research include Thomas Schwarz and James Larkin.
- 1 Thomas Schwarz United States 3.1k citations
- 2 James Larkin United Kingdom 2.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Tuberous Sclerosis Complex Research research done?
The largest centres of Tuberous Sclerosis Complex Research research in 2022–2025 are Beijing (China), Tokyo (Japan), Boston (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cincinnati.
Largest cities, 2022–2025
Where it is the local speciality
- CincinnatiUS · 23.2 works14×
Location quotient: how much more of its research is in Tuberous Sclerosis Complex Research than the world average.
Where is the best place to study Tuberous Sclerosis Complex Research?
Among universities, judged by research, Harvard University, University of Cincinnati and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 63.7 | 23.6% | 4.6× | 12 | -13.4% |
| 2 | University of CincinnatiUnited States | 50.7 | 4.8% | 16.5× | 10 | +64.1% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 45.2 | 5.0% | 6.8× | 14 | +7.9% |
| 4 | Post Graduate Institute of Medical Education and ResearchIndia | 44.9 | 0.3% | 13.5× | 9 | +165.3% |
| 5 | All India Institute of Medical SciencesIndia | 37.3 | 0.4% | 8.8× | 11 | +26.1% |
| 6 | Sichuan UniversityChina | 19.1 | 10.7% | 2.3× | 8 | +31.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Tuberous Sclerosis Complex Research research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Tuberous Sclerosis Complex Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.